GlaxoSmithKline plc (the 'Company')
Transaction notification
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
a) |
Name |
Mr S Dingemans |
|||
b) |
Position/status |
Chief Financial Officer |
|||
c) |
Initial notification/ amendment |
Initial Notification |
|||
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
Name |
GlaxoSmithKline plc |
|||
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
a) |
Description of the financial instrument |
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|||
b) |
Nature of the transaction |
The exercise of nil-cost options over Ordinary Shares granted on 12 February 2014 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. |
|||
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
|
£0.0000 |
22,448 (Deferred) |
|
||
|
£0.0000 |
7,483 (Matching) |
|
||
|
|
, |
|
||
d) |
Aggregated information |
|
|||
Aggregated volume Price |
29,931 £0.0000 |
||||
e) |
Date of the transaction |
2017-02-22 |
|||
f) |
Place of the transaction
|
n/a |
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
a) |
Name |
Mr S Dingemans |
|||
b) |
Position/status |
Chief Financial Officer |
|||
c) |
Initial notification/ amendment |
Initial Notification |
|||
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
Name |
GlaxoSmithKline plc |
|||
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
a) |
Description of the financial instrument |
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|||
b) |
Nature of the transaction |
The sale of Ordinary Shares to meet tax liabilities on nil-cost options over Ordinary Shares exercised on 22 February 2017 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. |
|||
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
|
£16.3850 |
10,763 (Deferred) |
|
||
|
£16.4007 |
3,589 (Matching) |
|
||
|
|
|
|
||
d) |
Aggregated information |
|
|||
Aggregated volume Price |
14,352 £16.3889 |
||||
e) |
Date of the transaction |
2017-02-22 |
|||
f) |
Place of the transaction
|
London Stock Exchange (XLON) |